Article info

Download PDFPDF

Towards clinical significance of the MUC5B promoter variant and risk of rheumatoid arthritis-associated interstitial lung disease
Free

Authors

  • Jeffrey A Sparks Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA 02115, USA Department of Medicine, Harvard Medical School, Boston, MA, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jeffrey A Sparks, Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA; jsparks{at}bwh.harvard.edu
View Full Text

Citation

Sparks JA
Towards clinical significance of the MUC5B promoter variant and risk of rheumatoid arthritis-associated interstitial lung disease

Publication history

  • Received July 6, 2021
  • Accepted July 21, 2021
  • First published August 3, 2021.
Online issue publication 
November 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.